AbbVie, Inc. v. Teva Pharmaceuticals, Inc. > Summary
Court Case Number 1:23-cv-00374
Filing Date Apr 3, 2023
Court Delaware District Court
Status Unknown
JudgesRichard G. Andrews
Plaintiff
Defendant
Plaintiff Attorneys
9AbbVie Inc.
Attorney Name: Jack B. Blumenfeld
Morris Nichols Arsht & Tunnell
AbbVie Inc.
Attorney Name: Jeremy A. Tigan
Morris Nichols Arsht & Tunnell
AbbVie Inc.
Attorney Name: Megan E. Dellinger
Morris Nichols Arsht & Tunnell
AbbVie Inc.
Attorney Name: William B. Raich
Finnegan, Henderson, Farabow, Garrett & Dunner
AbbVie Inc.
Attorney Name: Reinaldo Franqui Machin
Finnegan, Henderson, Farabow, Garrett & Dunner
AbbVie Inc.
Attorney Name: Ryan V. McDonnell
Finnegan, Henderson, Farabow, Garrett & Dunner
AbbVie Inc.
Attorney Name: Jennifer H. Roscetti
Finnegan, Henderson, Farabow, Garrett & Dunner
AbbVie Inc.
Attorney Name: Constance Pei Hwa Lee
Finnegan, Henderson, Farabow, Garrett & Dunner
AbbVie Inc.
Attorney Name: Danielle A. Duszczyszyn
Finnegan, Henderson, Farabow, Garrett & Dunner
Defendant Attorneys
3Teva Pharmaceuticals
Attorney Name: Karen E. Keller
Shaw Keller LLP
Teva Pharmaceuticals
Attorney Name: Emily S. Dibenedetto
Shaw Keller LLP
Teva Pharmaceuticals
Attorney Name: Nathan R. Hoeschen
Shaw Keller LLP
Related Patents
| Doc No | Title | Issue date |
|---|---|---|
| 11542239 | Elagolix sodium compositions and processes | Jan 3, 2023 |
